Curing method for pathologic syndrome and medicinal preparation

Abstract

A method of treating a pathological syndrome includes administration of an activated form of ultra-low doses of antibodies to an antigen, wherein said activated form is obtained by repeated consecutive dilution combined with external impact, and the antigen is a substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of this particular pathological syndrome. Pharmaceutical agent for treating a pathological syndrome contains activated form of ultra-low doses of monoclonal, polyclonal or natural antibodies to an antigen, wherein said activated form is prepared by means of repeated consecutive dilution and external treatment, predominantly based on homeopathic technology, and said antigen is a substance or a drug acting as a direct cause of the pathological syndrome or involved in regulation of mechanisms of its formation. At that, activated forms of ultra-low doses of antibodies are raised against antigens of exogenous or endogenous origin, against autologous antigens, fetal antigens; anti-idiotypic antibodies are used too.

1 . A method of treating a pathological syndrome by administration of activated forms of ultra-low doses of antibodies to an antigen, wherein said activated forms are obtained by repeated consecutive dilution combined with external treatment, and said antigen is a substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of the pathological syndrome.  
     
     
         2 . The method of treating a pathological syndrome described in  claim 1 , wherein said activated form of ultra-low doses of antibodies are produced by homeopathic technology.  
     
     
         3 . The method of treating a pathological syndrome described in  claim 1 , wherein said activated forms of ultra-low doses of antibodies to an antigen or hapten are administered together with this antigen, and said antigen or hapten is a substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of the pathological syndrome.  
     
     
         4 . A method of treating a pathological syndrome by administration of activated forms of ultra-low doses of antibodies to an antigen, wherein said pathological syndrome is caused by introduction of the antigen, said activated forms are obtained by repeated consecutive dilution combined with external treatment, and said antigen is a substance or a pharmaceutical agent capable of causing intoxication and/or addiction.  
     
     
         5 . The method of treating a pathological syndrome described in  claim 4 , wherein said activated form of ultra-low doses of antibodies are produced by homeopathic technology.  
     
     
         6 . The method of treating a pathological syndrome described in  claim 4 , wherein said activated forms of ultra-low doses of antibodies to an antigen or hapten are administered together with this antigen, and said antigen or hapten is a substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of the pathological syndrome.  
     
     
         7 . A method of treating a pathological syndrome by administration of activated forms of ultra-low doses of antibodies to an antigen, wherein said activated forms are obtained by repeated consecutive dilution combined with external treatment, and said antigen is a hapten conjugated with high-molecular compound, wherein said hapten is substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of the pathological syndrome.  
     
     
         8 . The method of treating a pathological syndrome described in  claim 7 , wherein said activated forms of ultra-low doses of antibodies are produced by homeopathic technology.  
     
     
         9 . The method of treating a pathological syndrome described in  claim 7 , wherein said activated forms of ultra-low doses of antibodies to an antigen or hapten are administered together with this antigen, and said antigen or hapten is a substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of the pathological syndrome.  
     
     
         10 . A method of treating a pathological syndrome by administration of activated forms of ultra-low doses of antibodies to an antigen, wherein said activated forms are obtained by repeated consecutive dilution combined with external treatment, said antigen is an antigen of a tissue or a tissue culture, and said antigen exerts influence upon the mechanisms of formation of pathological syndrome predominantly in this particular tissue.  
     
     
         11 . The method of treating a pathological syndrome described in  claim 10 , wherein said activated form of ultra-low doses of antibodies are produced by homeopathic technology.  
     
     
         12 . A pharmaceutical agent for treating a pathological syndrome containing an activated form of ultra-low doses of monoclonal, polyclonal or natural antibodies, wherein said activated form is produced by repeated consecutive dilution and external treatment predominantly based on homeopathic technology, and said antigen is a substance or a drug exerting influence upon the mechanisms of formation of the pathological syndrome.  
     
     
         13 . The pharmaceutical agent described in  claim 12 , wherein antibodies are raised to substances of exogenous origin.  
     
     
         14 . The pharmaceutical agent described in  claim 12 , wherein antibodies are raised to substances of endogenous origin.  
     
     
         15 . The pharmaceutical agent described in  claim 12 , wherein antibodies are raised to antigens of fetal tissues or tissue cultures.  
     
     
         16 . The pharmaceutical agent described in  claim 12 , wherein antibodies used are antiidiotypic antibodies.